|
GAPVD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.200800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.008650E-01 |
| Normal-vs-Stage2 |
8.292600E-01 |
| Normal-vs-Stage3 |
1.769870E-02 |
| Normal-vs-Stage4 |
7.017700E-03 |
| Stage1-vs-Stage2 |
1.914380E-01 |
| Stage1-vs-Stage3 |
7.72789999999857E-05 |
| Stage1-vs-Stage4 |
5.63059999999505E-05 |
| Stage2-vs-Stage3 |
1.355760E-01 |
| Stage2-vs-Stage4 |
6.848200E-02 |
| Stage3-vs-Stage4 |
5.628000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.313000E-01 |
| Normal-vs-AfricanAmerican |
1.668980E-01 |
| Normal-vs-Asian |
6.574000E-02 |
| Caucasian-vs-AfricanAmerican |
3.071400E-01 |
| Caucasian-vs-Asian |
1.638340E-02 |
| AfricanAmerican-vs-Asian |
2.762300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.795430E-01 |
| Normal-vs-Female |
2.884200E-01 |
| Male-vs-Female |
1.042140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.110000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.219800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.613650E-01 |
| Normal-vs-Age(81-100Yrs) |
2.975000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.180600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.876000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.968800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.830230E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.531050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.658200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.124400E-03 |
| Normal-vs-Grade 2 |
8.737900E-02 |
| Normal-vs-Grade 3 |
1.260180E-01 |
| Normal-vs-Grade 4 |
8.190500E-04 |
| Grade 1-vs-Grade 2 |
1.704600E-01 |
| Grade 1-vs-Grade 3 |
6.037700E-03 |
| Grade 1-vs-Grade 4 |
3.764800E-04 |
| Grade 2-vs-Grade 3 |
6.203600E-04 |
| Grade 2-vs-Grade 4 |
1.65340000002345E-06 |
| Grade 3-vs-Grade 4 |
1.536150E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.200100E-04 |
| Normal-vs-ccB subtype |
1.508010E-02 |
| ccA subtype-vs-ccB subtype |
1.63799995789304E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.857400E-01 |
| Normal-vs-N1 |
4.945000E-01 |
| N0-vs-N1 |
4.515800E-01 |
|
|
